Angela K. Phillips

Angela K. Phillips

Auto-generated profile, based on publicly available information

Angela K. Phillips

Daniel K. Inouye Graduate School of Nursing, Uniformed Services University of the Health Sciences , Bethesda, MD 20814, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2022 in Journal of PeriAnesthesia Nursing
Verified
Journal Article
Closed access
TRTeisha St. Rose
Teisha St. Rose
SCStacy N. Carr
Stacy N. Carr
APAngela K. Phillips
Angela K. Phillips
NRNicholas P. Reeder
Nicholas P. Reeder
MRMichael Relf
Michael Relf

26 November 2021 in Military Medicine
Verified
Journal Article
Open access
PDF file
SIStacey E Iobst
Stacey E Iobst
APAngela K Phillips
Angela K Phillips
Candy WilsonCandy Wilson
Candy Wilson
The cesarean birth rate of 24.7% in the Military Health System (MHS) is lower than the national rate of 31.7%. However, the MHS rate remains higher than the 15-19% threshold associated with optimal maternal and neonatal outcomes. For active duty servicewomen, increased morbidity associated with cesarean birth is likely to affect the ability to meet the demands of assigned missions. Several decision-points occur during pregnancy and after the onset of labor that can affect the likelihood of cesarean birth including choice of provider, choice of hospital, timing of admission, and type of fetal monitoring. Evidence suggests the overuse of labor interventions may be associated with cesarean birth. Shared decision-making (SDM) is a strategy that can be used to carefully consider the risks, benefits, and alternatives of each labor intervention and is shown to be associated with positive patient outcomes. Most existing evidence explores SDM as an interaction that occurs between women and their providers. Few studies have explored the role of stakeholders such as spouses, family members, friends, labor and delivery nurses, and doulas. Furthermore, little is known about the process of SDM during labor and childbirth in the hospital setting, particularly for active duty women in the U.S. military. The purpose of this study was to propose a framework that explains the process of SDM during labor and childbirth in the hospital setting for active duty women in the U.S. military. A qualitatively driven mixed-methods approach was conducted to propose a framework that explains the process of SDM during labor and childbirth in the hospital setting for active duty women in the U.S. military. Servicewomen were recruited from September 2019 to April 2020. Semi-structured interviews were analyzed using a constructivist grounded theory approach. Participants also completed the SDM Questionnaire (SDM-Q-9). Interviews were conducted with 14 participants. The sample included servicewomen from the Air Force (n = 7), Army (n = 4), and Navy (n = 3). Two participants were enlisted and the remainder were officers. Ten births occurred at military treatment facilities (MTFs) and four births took place at civilian facilities. The mean score on the SDM Questionnaire was 86.7 (±11.6), indicating a high level of SDM. Various stakeholders (e.g., providers, labor and delivery nurses, doulas, spouses, family members, and friends) were involved in SDM at different points during labor and birth. The four stages of SDM included gathering information, identifying preferences, discussing options, and making decisions. Events that most often involved SDM were deciding when to travel to the hospital, deciding when to be admitted, and selecting a strategy for pain management. Military factors involved in SDM included sources of information, selecting and working with civilian providers, and delaying labor interventions to allow time for an active duty spouse to travel to the hospital. SDM during labor and birth in the hospital setting is a multi-stage process that involves a variety of stakeholders, including the woman, members of her social and support network, and healthcare professionals. Future research is needed to explore perspectives of other stakeholders involved in SDM.

14 October 2022 in Military Medicine
Verified
Journal Article
Open access
PDF file
SIStacey E Iobst
Stacey E Iobst
NBNatasha Best
Natasha Best
DSDenise C Smith
Denise C Smith
MPMajor Angela K Phillips
Major Angela K Phillips
Candy WilsonCandy Wilson
Candy Wilson
LTLori Trego
Lori Trego
Although active duty women (ADW) represent over 17% of the total U.S. Armed Forces, there are few evidence-based guidelines to promote the health of women who serve in contemporary military roles. The existing body of evidence does not support guideline development because much of the evidence is not generalizable to ADW. The authors of this commentary recently conducted seven scoping reviews of the literature relevant to ADW’s health and healthcare. While completing the literature reviews, it was noted that a substantial proportion of military studies either do not include ADW as research participants or fail to examine findings according to sex and/or active duty status. The authors of this commentary outline a rigorous, step-by-step approach to research design in which ADW are accounted for at every stage of the process. Furthermore, this team of authors identifies opportunities for key stakeholders to provide oversight of the research process to ensure rigorous methodology that includes ADW. Implementing these strategies is critical to building the evidence on which to support the health and healthcare of ADW, who represent a substantial and growing component of the U.S. Military. Optimizing the health of this population is critical to maintaining the strength and readiness of our U.S. Armed Forces.

1 April 2024 in Women's Health Reports
Verified
Journal Article
Open access
APAngela K. Phillips
Angela K. Phillips
LSLaura Segovia
Laura Segovia
ALAlicia A. Livinski
Alicia A. Livinski
CWCandy Wilson
Candy Wilson
ASArun S. Shet
Arun S. Shet
MBMargaret Bevans
Margaret Bevans
Although there is an emerging body of evidence that addresses the adverse health outcomes of individuals with sickle cell trait (SCT), it is not clear if the findings are generalizable from a sex and gender perspective. The purpose of this scoping review was to complete an assessment of main concepts, identify knowledge gaps, and determine the potential value of conducting an eventual systematic review. The research question guiding this scoping review is: In SCT individuals with adverse health outcomes, what is known about sex and gender differences? We conducted a scoping review of research on SCT from 2016 to 2022 across five databases, with 36 research studies included in the review. The majority of the included studies were cohort studies (67%) in the United States (61%) focusing on a variety of health outcomes. One-third reported health outcomes by both SCT status and sex, and one-third controlled for sex; no studies addressed gender. Further research is needed on the role of sex and gender for individuals with SCT.

28 December 2022 in Nursing Outlook
Verified
Journal Article
Open access
APAngela K. Phillips
Angela K. Phillips
JBJennifer J. Buechel
Jennifer J. Buechel
FDFrank C. Druse
Frank C. Druse
DHDawnkimberly Hopkins
Dawnkimberly Hopkins
POPedro N. Oblea
Pedro N. Oblea
CWCandy S. Wilson
Candy S. Wilson
The Military Women's Health Research Interest Group (MWHRIG) was established in 2010. The purpose of the MWHRIG is to support military clinicians and leaders in determining research priorities, and making evidence-based practice and policy decisions relevant to sex- and gender-appropriate healthcare. This article highlights the history of the MWHRIG, and current activities inclusive of research, mentorship, and collaboration. Future activities for the MWHRIG will focus on continued use of a theoretical framework for military women's health research, inclusivity of gender sexual diversity (GSD), and metrics for future success.

6 April 2025 in AJOG Global Reports
Verified
Journal Article
Open access
APAngela K. Phillips
Angela K. Phillips
CWCandy Wilson
Candy Wilson
AAAnwar E. Ahmed
Anwar E. Ahmed
ASArun Shet
Arun Shet
MBMargaret Bevans
Margaret Bevans
Sickle cell trait is the carrier state for sickle cell disease and occurs in 1 in 13 births in Black and African American families. Individuals with sickle cell trait are permitted to serve in the military. Some research studies have shown that individuals with sickle cell trait may be at increased risk for thromboembolic events. Contraceptive use, specifically combined hormonal contraceptives containing both estrogen and progesterone, has been linked to an increased risk of thromboembolic events. No research has been done to determine if there is an increased risk of venous thromboembolism in a population of females with sickle cell trait who do or do not take combined hormonal contraceptives. To determine if women with sickle cell trait who use combined hormonal contraceptives are at higher risk for venous thromboembolism compared with females with sickle cell trait who do not use combined hormonal contraceptives. Given the increased risk of venous thromboembolism in sickle cell trait individuals in the general population, we hypothesized that females with sickle cell trait exposed to combined hormonal contraceptives would experience higher venous thromboembolism rates than unexposed females with sickle cell trait. Population-based retrospective cohort study of females with sickle cell trait identified from the Military Data Repository to evaluate venous thromboembolism after exposure to combined hormonal contraceptives or without exposure to combined hormonal contraceptives. There were 15,440 unique females aged 18-44 years between 2005 and 2021 who had a diagnosis of sickle cell trait. Approximately 40% of females had an International Classification of Diseases code consistent with a prescription of a combined hormonal contraceptive. Thirty-three (0.2%) of the 15,440 females with sickle cell trait had experienced venous thromboembolism of any type. There was no difference in the prevalence of venous thromboembolism by combined hormonal contraceptive use (yes [0.18%] vs no [0.24%]; P=.454). Being older, married, nonactive-duty military status, smoking, and having a diagnosis of hypertension were associated with a higher prevalence of venous thromboembolism. Although there was a small number of venous thromboembolism events, the findings of this study suggest that the use of combined hormonal contraceptives in females with sickle cell trait is not associated with a detectable signal for increased venous thromboembolism risk as an outcome. Given the potential clinical benefit of combined hormonal contraceptives in pregnancy prevention and menstrual regulation in females, the concerns about combined hormonal contraceptive-associated venous thromboembolism in this population with sickle cell trait seem to be minimal.